Allostery-Investments-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
41
Total Value
69335050
Accession Number
0001013594-25-000654
Form Type
13F-HR
Manager Name
Allostery-Investments-Lp
Data Enrichment
95% identified
39 identified2 unidentified

Holdings

41 positions
Manager:
Search and click to pin securities to the top
Page 1 of 3
Abivax S.A.
Shares:1.1M
Value:$6.9M
Centessa Pharmaceuticals plc
Shares:382.5K
Value:$5.5M
KalVista Pharmaceuticals, Inc.
Shares:458.3K
Value:$5.3M
Merus N.V.
Shares:124.7K
Value:$5.2M
Evolus, Inc.
Shares:412.8K
Value:$5.0M
Apogee Therapeutics, Inc.
Shares:110.0K
Value:$4.1M
Alkermes plc.
Shares:115.0K
Value:$3.8M
008064107
Shares:1.4M
Value:$3.6M
Zura Bio Ltd
Shares:2.3M
Value:$3.0M
Arcellx, Inc.
Shares:44.0K
Value:$2.9M
CYTOKINETICS INC
Shares:70.0K
Value:$2.8M
BridgeBio Pharma, Inc.
Shares:80.0K
Value:$2.8M
SpringWorks Therapeutics, Inc.
Shares:52.5K
Value:$2.3M
Beam Therapeutics Inc.
Shares:92.8K
Value:$1.8M
SOLENO THERAPEUTICS INC
Shares:20.0K
Value:$1.4M
Vaxcyte, Inc.
Shares:32.0K
Value:$1.2M
IONIS PHARMACEUTICALS INC
Shares:35.0K
Value:$1.1M
Xenon Pharmaceuticals Inc.
Shares:30.0K
Value:$1.0M
Amylyx Pharmaceuticals, Inc.
Shares:266.1K
Value:$942.0K
Avalo Therapeutics, Inc.
Shares:107.1K
Value:$858.2K